CN1616001A - Hemorrhoid treating medicine - Google Patents
Hemorrhoid treating medicine Download PDFInfo
- Publication number
- CN1616001A CN1616001A CN 200410073063 CN200410073063A CN1616001A CN 1616001 A CN1616001 A CN 1616001A CN 200410073063 CN200410073063 CN 200410073063 CN 200410073063 A CN200410073063 A CN 200410073063A CN 1616001 A CN1616001 A CN 1616001A
- Authority
- CN
- China
- Prior art keywords
- hemorrhoid
- medicine
- minutes
- blood
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The pile treating medicine consists of alum 1-3 (in weight portions, the same below), verdigris 1-2, sophora fruit 13-23, basket kern 4-8, borneol 1-3, garden burnet 10-16, fig 20-30, metronidazole 0.4-0.8 and dexamethasone 0.001-0.002. The medicine is used in treating piles through combined soaking and sticking, and has fast hemostasis, antipruritic and detumescent effect, short heating period, simple use and no toxic side effect.
Description
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of hemorrhoid treating medicine that adopts raw material of Chinese medicine and chemicals raw material.
Background technology
Hemorrhoid are to expand because of the vein stagnation of the blood of anus or rectum end, form the lesser tubercle of projection.Mainly be divided into two kinds of internal hemorrhoid and external hemorrhoids, symptom is for itching, and is scorching hot, pain, stool band blood etc.It belongs to a kind of commonly encountered diseases, and saying so-called " ten male nine hemorrhoid " is exactly the preferably description to its universality.So the medicine of treatment hemorrhoid that is seen in report at present is many,
Summary of the invention
It is the medicine of the treatment hemorrhoid of one with raw material of Chinese medicine and the combination of chemicals raw material that the object of the invention provides a kind of.
The medicine of treatment hemorrhoid of the present invention is to be made by the raw material of following weight portion:
White sail 1-3, Aerugo 1-2, Fructus Sophorae 13-23, Rhizoma Osmundae 4-8, Borneolum Syntheticum 1-3, Radix Sanguisorbae 10-16, Fructus Fici 20-30, metronidazole 0.4---0.8, dexamethasone 0.001-0.002.
The preferential pharmaceutical formulation of recommending of the present invention is:
White sail 2, Aerugo 1.5, the Fructus Sophorae 18, Rhizoma Osmundae 6, Borneolum Syntheticum 2, Radix Sanguisorbae 13, Fructus Fici 25, metronidazole 0.6, dexamethasone 0.001.
The present invention adopts the Chinese and western drugs reasonable compatibility, has both absorbed the advantage of chemicals instant effect, has inherited Chinese medicine conditioning human body again from stop the strong point of disease recurrence at all.Medicine of the present invention is the bonded method treatment of external immersion and external application affected part, has quick-acting haemostatic powder, antipruritic and repercussive effect, can eradicate hemorrhoid in the short time and does not recur.And use simply, have no side effect.
The specific embodiment
1, decocting liquid soaks: white sail 2 grams, Aerugo 1.5 grams, the Fructus Sophorae 18 grams, Rhizoma Osmundae 6 grams, Borneolum Syntheticum 2 grams, Radix Sanguisorbae 13 grams, the Fructus Fici 25 grams after drying of weighing is pulverized, mixed, reheat decocted 30-40 minute after being soaked in water 20 minutes, decocting liquid and medicinal residues are placed clean demibain container together, metronidazole 0.6 gram and the dexamethasone 0.001 that add porphyrize restrain holding temperature about 30 degree, and demibain was soaked 30 minutes.
2, unguentum external application.White sail 2 grams, Aerugo 1.5 grams, the Fructus Sophorae 18 grams, Rhizoma Osmundae 6 grams, Borneolum Syntheticum 2 grams, Radix Sanguisorbae 13 grams, the Fructus Fici 25 grams after drying of weighing is pulverized, mixed, cross 60 mesh sieves, metronidazole 0.6 gram and dexamethasone 0.001 gram with porphyrize adds in the Chinese medicine powder then, add vegetable oil again and make unguentum, get 5 and restrain outer being attached on the anus, keep more than 40 minutes.
3, treatment is carried out once or twice every day.
Medicine of the present invention proves that through the clinical for many years use of inventor curative effect is infallible.It below is Drug therapy hemorrhoid patients clinical report of the present invention.
First: basic standard
One, case is selected
(1) Western medicine diagnose standard
Diagnostic classification standard and Ministry of Public Health new Chinese medicine clinical research in 1993 guideline according to national first anorectal in 1975 academic conference are formulated following diagnostic criteria.
1, external hemorrhoid
(1) thrombosed external hemorrhoid: because of haemorrhoidal vein breaks, clot condenses in subcutaneous, forms thrombosis, and swollen thing occurs,
(2), inflammatory external hemorrhoid: local red and swollen, the pain of blood stasis, and edema and hyperemia are arranged.
2, internal hemorrhoid
(1) I phase internal hemorrhoid: the very for a short time purple that is of blood stasis, matter is soft, and often hemorrhage because of the stool friction, blood stasis does not have.
(2) II phase internal hemorrhoid: blood stasis is bigger, is purple dim color, and mucosa thickens coarse, and blood stasis is deviate from outside the anus in the time of just, and after an action of the bowels from horizontal reset, amount of bleeding is less.
(3) III phase internal hemorrhoid: blood stasis is grey dim color, and matter is harder, and mucosa thickens coarse, and it is little to have blood in stool, and not only blood stasis is deviate from during defecation, even also deviates from when squatting down, coughing or walking.
3, mixed hemorrhoid
Being positioned at the tooth trace upper and lower all has blood stasis, the inside and outside hemorrhoid two aspect symptoms of tool.
4, diagnose in conjunction with following symptom and inspection by above diagnostic criteria
(1) symptom
1. after an action of the bowels archorrhagia, bleed or penetrate blood.
2. just the time or firmly the time, blood stasis is deviate from outside the anus, but can reset from horizontal reset or hand push.
3. anus discomfort after an action of the bowels, the companion weighs down pain.
(2) inspection: the anus skin weighs down congested, and blood stasis becomes big when increasing abdominal pressure, and part patient's blood stasis is deviate from outside the anus.
(3) anoscopy: the bossed blood stasis in tooth trace place, the hemorrhoid mucosa has inflammation, and secreting mucus or companion are rotten to the corn.
(4) digital rectal examination: get rid of other pathological changes such as rectal cancer or rectal polyp.Above-mentioned 3 of meeting in (1) or (2), (3) bar, promptly diagnosable.
(2) Chinese medical discrimination
Wind is hindered the intestinal network: stool band blood, bleed or spurting hemorrhage, color is scarlet, or pruritus ani is arranged.Red tongue, white and thin fur or BOHUANG, floating and rapid pulse.
Damp invasion of lower energizer: the color aquatic foods of having blood in stool, to measure morely, swollen beyond the region of objective existence takes off in the anus, can bounce back burning sensation of the anus or swell and ache voluntarily.Red tongue, yellow and thin fur or yellow greasy, stringy and rolling pulse or sliding number.
Two, test case standard
(1) includes standard in
All Western medicine diagnoses that meets, and meet Chinese medical discrimination and belong to wind and hinder intestinal network and damp invasion of lower energizer person, all can include the test case in.
All Western medicine diagnoses that meets, and meet Chinese medical discrimination and belong to wind and hinder intestinal network and damp invasion of lower energizer person, all can include the test case in.
(2) exclusion standard
1, suffers from severe cardiac, liver, kidney disease patient.
2, be reluctant to accept to observe the case that maybe can not finish statistics by the design requirement.
3, suffer from multiple disease, hold concurrently folder disease, complication are difficult for judged result person.
4, the women of gravid woman and preparation gestation.
Three, grouping and control drug
Case be will include in,, test group and matched group will be divided at random, test group 218 examples, matched group 100 examples by the table of random number method.
Inactive all medicines relevant during the treatment (for oral administration and external) with this disease.
(1) trial drug: water decoction 1000ml demibain of the present invention is soaked, once a day; Every 5g of ointment, (5g) once a day injects anal or is coated with the affected part.All medicine logotypes 7 days.
(2) control drug: the domestic same veriety that gone on the market
Packing 10g/ props up.Usage, consumption, the course of treatment same test group.
Four, observation index
(1) safety indexes
1. general health check-up project.
2. blood, urine, just routine examination.
3. the heart, liver, kidney function test.
(2) health giving quality index
1, related symptoms, sign.
2, anoscopy.
Five, curative effect determinate standard
Curative effect of disease (drafting) according to national anorectal academic conference formulation standard in 1975
(1) recovery from illness: do not have hemorrhagely after an action of the bowels, do not have prolapsus, it is normal that anoscopy hemorrhoid mucosa recovers, the blood stasis atrophy.
(2) produce effects: do not have hemorrhagely after an action of the bowels, nothing is deviate from, and the blood stasis redness obviously disappears, and pain disappears.Anoscopy, internal hemorrhoid mucosa mild hyperaemia, blood stasis diminishes.
(3) take a turn for the better: have after an action of the bowels hemorrhage on a small quantity, pain relief, the companion is prolapsus slightly, anoscopy hemorrhoid mucosa mild hyperaemia.
(4) invalid: after the medication clinical symptoms anoscopy with control Wen Qianwu and be clearly better or increase the weight of.
Clinical symptoms, sign comprehensive therapeutic effect standard
Consider that the external traditional Chinese herb medicine still can not use internal hemorrhoid and external hemorrhoid atrophy of connective tissue type or disappearance, only can make part hemorrhoid edema or thrombosed hemorrhoids dwindle.So in clinical trial our emphasis according to hemorrhoid cause hemorrhage, deviate from, pain and hemorrhoid mucosa state, several symptoms of external hemorrhoid edema are carried out primary part observation, do not observe the blood stasis atresia.When respecting above-mentioned standard, each cardinal symptom is quantized according to light and heavy degree, the evaluation score value, the score value before and after the last foundation treatment is added up, and judges curative effect.Every routine total points is up to 40 fens, and the expression symptom and sign all disappears, and symptom is heavy more, and score value is low more.When clinical card shape, sign comprehensive therapeutic effect are judged, with score value as foundation.
Be almost recovered: 40 minutes.Be meant all kinds of transference cures of hemorrhoid, but blood stasis exists still, can be called the symptom recovery from illness.
Produce effects: 38-36 branch (or score value increases more than 10 minutes and 10 minutes before the treatment).
Effectively: 36-32 branch (or score value increases more than 6 minutes and 6 minutes before the treatment).
Invalid: treatment is preceding, treatment back score value does not have significant change, or score value increases below 3 minutes.
Concrete standards of grading are seen attached list.
Subordinate list: clinical card shape, sign comprehensive observing standards of grading and curative effect standards of grading
1, has blood in stool | Nothing is had blood in stool | 8 minutes | Weigh down pain | 6 minutes | |
Band blood | 6 minutes | Severe pain | 3 minutes | ||
Bleed | 4 minutes | 4, mucosa | Normally | 8 minutes | |
Penetrate blood | 2 minutes | Congested | 6 minutes | ||
2, prolapsus | There is not prolapsus | 8 minutes | Rotten to the corn | 4 minutes | |
Can be from horizontal reset | 6 minutes | The petechia | 2 minutes |
Reset after the rest | 4 minutes | 5, external hemorrhoid | No edema redness | 8 minutes | |
Hand push resets | 2 minutes | Edema | The external hemorrhoid edema | 6 minutes | |
Can not reset | 0 minute | The external hemorrhoid redness | 4 minutes | ||
3, pain | There are not the pain of bob and pain | 8 minutes | The external hemorrhoid erosion | 2 minutes |
Second portion: physical data
One, experimental condition and sex composition (example)
Group | Add up to | Experimental condition | Sex | ||
Be in hospital | Outpatient service | The man | The woman | ||
Test group | ????218 | ??38 | ??180 | ??134 | ??84 |
Matched group | ????100 | ??54 | ??46 | ??68 | ??32 |
Two, the age:
Table 2 age distribution situation (example)
Group | Add up to | ????20- | ????30- | ??40- | ??50- |
Test group | ????218 | ????21 | ????99 | ??55 | ??43 |
Matched group | ????100 | ????16 | ????35 | ??46 | ??3 |
Three, the course of disease distributes:
Table 3 course of disease distribution (example)
Group | Add up to | ≤ 1 year | -10 years | -20 years | -30 years | More than 30 years |
Test group | 218 | 98 | 68 | 31 | 13 | 8 |
Matched group | 100 | 65 | 16 | 9 | 6 | 4 |
Four, disease: the relative analysis of primary symptom
Respectively organize the clinical symptoms statistical table before table 4 treatment
Classification | Primary symptom | Test group | Matched group | The P value | ||
Example % | Example % | |||||
Have blood in stool | Band blood | 68 | ?31.2 | ?29 | ?29 | >0.05 |
Bleed | 87 | ?39.9 | ?31 | ?31 | ||
Penetrate blood | 57 | ?25.1 | ?26 | ?26 | ||
Hemorrhoid are taken off | Can recover voluntarily | 41 | ?18.9 | ?11 | ?11 | >0.05 |
Hand push recovers | 76 | ?35.0 | ?38 | ?38 | ||
Can not recover | 32 | ?14.6 | ?11 | ?11 | ||
Proctalgia | Weigh down pain | 124 | ?57.0 | ?62 | ?62 | >0.05 |
Severe pain | 89 | ?40.9 | ?40 | ?40 | ||
The hemorrhoid mucosa | Congested | 117 | ?53.7 | ?58 | ?58 | >0.05 |
Rotten to the corn | 56 | ?25.6 | ?29 | ?29 | ||
The petechia | 34 | ?15.6 | ?17 | ?17 | ||
Local inspection | The external hemorrhoid edema | 26 | ?11.9 | ?13 | ?13 | >0.05 |
The external hemorrhoid redness | 48 | ?22.0 | ?26 | ?26 | ||
The external hemorrhoid erosion | 16 | ?7.34 | ?8 | ?8 |
Third part: result
For continuous use 7 days patient of Drug therapy of the present invention and matched group patient, the symptom combined treatment standard after 7 days is added up as following table:
The result | Test group | Matched group | ||
The example number | ?% | The example number | ?% | |
Be almost recovered | 169 | ?77.5 | ?54 | ?54 |
Produce effects | 27 | ?12.4 | ?13 | ?13 |
Effectively | 24 | ?11.1 | ?2 | ?2 |
Invalid | 8 | ?3.7 | ?31 | ?31 |
The test group aggregate efficiency is 96.3%, and the matched group total effective rate only is 69%.Prove that medicine of the present invention has good therapeutic effect for various hemorrhoid, and effect is significantly better than existing medicine.
In full trimestral visit was examined subsequently, test group had 167 people's feedback informations, and wherein 158 people do not have recurrence, and 9 people all be the heavy worker, caused having slight rebound phenomenon owing to overworked, did not influence the judgement to this curative effect of medication.
Claims (2)
1, a kind of medicine for the treatment of hemorrhoid is characterized in that being made by the raw material of following weight portion:
White sail 1-3, Aerugo 1-2, Fructus Sophorae 13-23, Rhizoma Osmundae 4-8, Borneolum Syntheticum 1-3, Radix Sanguisorbae 10-16, Fructus Fici 20-30, metronidazole 0.4---0.8, dexamethasone 0.001---0.002.
2, a kind of medicine for the treatment of hemorrhoid according to claim 1 is characterized in that being made by the raw material of following weight portion:
White sail 2, Aerugo 1.5, the Fructus Sophorae 18, Rhizoma Osmundae 6, Borneolum Syntheticum 2, Radix Sanguisorbae 13, Fructus Fici 25, metronidazole 0.6, dexamethasone 0.001.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100730636A CN100333743C (en) | 2004-09-02 | 2004-09-02 | Hemorrhoid treating medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100730636A CN100333743C (en) | 2004-09-02 | 2004-09-02 | Hemorrhoid treating medicine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1616001A true CN1616001A (en) | 2005-05-18 |
CN100333743C CN100333743C (en) | 2007-08-29 |
Family
ID=34765245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100730636A Expired - Fee Related CN100333743C (en) | 2004-09-02 | 2004-09-02 | Hemorrhoid treating medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100333743C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920854A (en) * | 2012-10-19 | 2013-02-13 | 遵义市成云中医药研究所 | Chinese medicinal injection for treating hemorrhoids and fistula |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1024755C (en) * | 1989-05-30 | 1994-06-01 | 崔明华 | Chemicals curing piles |
CN1060084C (en) * | 1998-03-06 | 2001-01-03 | 陈德军 | Fast-acting hemorrhoidal pills |
-
2004
- 2004-09-02 CN CNB2004100730636A patent/CN100333743C/en not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102920854A (en) * | 2012-10-19 | 2013-02-13 | 遵义市成云中医药研究所 | Chinese medicinal injection for treating hemorrhoids and fistula |
CN102920854B (en) * | 2012-10-19 | 2014-09-10 | 遵义市成云中医药研究所 | Chinese medicinal injection for treating hemorrhoids and fistula |
Also Published As
Publication number | Publication date |
---|---|
CN100333743C (en) | 2007-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103830632A (en) | Chinese traditional medicine preparation for radically treating psoriasis and multiple skin diseases and preparation method and application thereof | |
CN1915375A (en) | Chinese traditional medicine for expeling wind and cold, relaxing muscles and tendons, harmonizing link and alleviating pain, and method for fabricating dog skin plaster purpose made | |
CN101057940A (en) | Apoplexy recover pills | |
CN1927322A (en) | Liposoluble traditional medicine bougie for treating acute and chronic prostatitis, and manufacturing technique thereof | |
CN1117582C (en) | medicine for treating rheumatoid arthritis and preparing process thereof | |
CN1895433A (en) | Chinese-medicinal composition for treating acne, its preparation and use | |
CN104524247B (en) | One treats migrainous medical composition and its use | |
CN1251748C (en) | Lotion for treating gynecological disease and its preparation process | |
CN103768357B (en) | A kind of Traditional Chinese medicine compound composition with treatment recurrent aphtha | |
CN1310664C (en) | Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process | |
CN1240412C (en) | Chinese medicine compound preparation for treating piles and preparing process thereof | |
CN102258601B (en) | Ointment for treating hemorrhoids | |
CN1616001A (en) | Hemorrhoid treating medicine | |
CN103301305A (en) | Traditional Chinese medicine for treating prostatic hyperplasia | |
CN1234407C (en) | Medicine for treating chronic prostatitis and its preparing method | |
CN1285362C (en) | Medicine for treating bleeding due to piles and other anorectal disease and the preparation method thereof | |
CN1682915A (en) | Medicine for treating pelvic inflammation and preparation method thereof | |
CN1203877C (en) | Chinese medicine preparation for curing hemorrhoidal bleeding | |
CN1772239A (en) | Chinese medicine prepn for treating vaginitis and cervicitis | |
CN108042601A (en) | A kind of drug for treating acute and chronic soft tissue injury and preparation method thereof | |
CN101554438A (en) | Traditional Chinese medicine for curing hemorrhoids | |
CN106975044A (en) | It is a kind of to treat medicine of calculus and its preparation method and application | |
CN1299752C (en) | Traditional Chinese medicine capsule for treating urinary calculus and its prepn. method | |
CN100509003C (en) | Medicament of treating psoriasis | |
CN100349592C (en) | Chinese medicine composition for treating bone disease, its preparation and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |